Topic archive

food and drug administration

13 stories

10/9/2026

FDA faces internal dissent over HHS peptide legalization

HHS plans to allow unapproved peptides, sparking FDA staff concerns.

10/8/2026

Study finds significant symptom improvement in PTSD, depression after ibogaine treatment.

9/22/2026

Model's overdose at Malibu rehab prompts scrutiny of ibogaine use.

9/4/2026

States advised to anticipate FDA approval of psychedelics for medical use.

8/20/2026

Dr. Heidi Overton, nominated by Trump, expedited psychedelic research policy.

8/19/2026

U.S. federal actions could accelerate ibogaine's medical potential

8/19/2026

The executive order aims to expedite research on ibogaine and other psychedelics.

8/19/2026

Ibogaine, a psychedelic drug, gains federal attention for treating addiction.

8/18/2026

Governor's order initiates ibogaine, MDMA, and psilocybin study

8/18/2026

Ibogaine remains illegal in the US despite its potential therapeutic benefits.

8/14/2026

New FDA guidance aligns with Veterans Affairs' psychedelics initiatives.

7/24/2026

White House adviser Heidi Overton shapes ibogaine policy amid internal disputes.

7/22/2026

Trump's 2026 executive order boosts psychedelic research funding and collaboration.